聯合CEO梁孟鬆提交辭呈 中芯國際(0981.HK)復牌一度跌近10%
格隆匯12月16日丨A股中芯國際上午盤中一度跌近10%後,上午停牌的港股中芯國際午後復牌一度跳水跌9.65%至19.2港元,股價創10月以來新低。A股目前跌幅收窄至7%以內。中芯國際聯合CEO梁孟鬆提交辭呈,公司稱目前正積極與樑博士核實其真實辭任之意願;此外,繼納斯達克指數後,中芯國際又遭MSCI從全球可投資市場指數中剔除,因美國政府11月發佈有關美國投資者不得交易部分中國企業股票的指令。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.